Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3′-[5-(1-hydroxy-1-methyl- ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain

1. Munro, G.
2. Lopez-Garcia, J.A.
3. Rivera-Arconada, I.
4. Erichsen, H.K.
5. Nielsen, E.Ø.
6. Larsen, J.S.
7. Ahring, P.K.
8. Mirza, N.R.